MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2026-03-31.

Cash Flow Overview

Free Cash flow
-$4,003K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Stock-based compensation
    • Prepaid expenses and other asset...
    • Asset sale proceeds
    • Depreciation and amortization
Negative Cash Flow Breakdown
    • Net loss
    • Accrued expenses
    • Accounts payable
    • Net gain on disposal of property...

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
-1,477 --
General and administrative
-1,057 --
Total operating expenses
-2,534 --
Amortization of right of use asset
-0 0 0
Other income, net
-163 --
Net loss
-4,003 -2,371 -2,392 -3,935
Depreciation and amortization
1 1 2 0
Net gain on disposal of property and equipment
3 0 0 0
Stock-based compensation
318 274 113 94
Prepaid expenses and other assets
-74 -343 269 165
Lease liability
-0 0 0
Accounts payable
-175 -80 281 -18
Accrued expenses
-215 -246 180 209
Net cash used in operating activities
-4,003 -2,079 -2,085 -3,815
Asset sale proceeds
3 0 --
Cash paid for purchase of property and equipment
0 0 7 5
Net cash provided by (used in) investing activities
3 0 -7 -5
Net proceeds from the exercise of warrants
0 2,835 200 2,720
Net proceeds from the issuance of common stock and warrants
0 9,570 1,852 6,493
Cash-in-lieu of fractional shares from reverse stock split
-0 --
Payments to repurchase shares withheld for payroll taxes from restricted stock issuance
-0 30 0
Net cash provided by financing activities
0 12,405 2,022 9,213
Net increase (decrease) in cash, cash equivalents and restricted cash
-4,000 10,326 5,323 -
Cash, cash equivalents and restricted cash at the beginning of period
21,031 10,705 5,382 -
Net increase (decrease) in cash and cash equivalents
---5,393
Cash, cash equivalents and restricted cash at end of period
17,031 21,031 10,705 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Asset sale proceeds$3K Net cash provided by(used in) investing...$3K Net increase(decrease) in cash, cash...-$4,000K Canceled cashflow$3K Stock-based compensation$318K Prepaid expenses andother assets-$74K Depreciation andamortization$1K Net cash used inoperating activities-$4,003K Canceled cashflow$393K Net loss-$4,003K Accrued expenses-$215K Accounts payable-$175K Net gain on disposalof property and...$3K

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp. (PHIO)